AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.7220
-0.1047 (-12.66%)
Jun 3, 2026, 10:02 AM EDT - Market open
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $11.37 million as of June 3, 2026. Its market cap has increased by 83.05% in one year.
Market Cap
11.37M
Enterprise Value
11.71M
1-Year Change
83.05%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since July 12, 1996, AIM ImmunoTech's market cap has decreased from $40.85M to $11.37M, a decrease of -72.17%. That is a compound annual growth rate of -4.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 13.01M | 303.68% |
| Dec 31, 2025 | 3.22M | -74.47% |
| Dec 31, 2024 | 12.63M | -41.22% |
| Dec 29, 2023 | 21.49M | 43.27% |
| Dec 30, 2022 | 15.00M | -65.93% |
| Dec 31, 2021 | 44.02M | -39.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 13.51M |
| CytoMed Therapeutics | 13.49M |
| Cadrenal Therapeutics | 13.39M |
| Moleculin Biotech | 13.13M |
| Theriva Biologics | 13.13M |
| Phio Pharmaceuticals | 13.01M |
| BioVie | 12.82M |
| HCW Biologics | 12.82M |